UBS Group
CEL

UBS Group’s Cellcom Israel, Ltd. CEL Stock Holding History

UBS Group’s Portfolio CEL Stock Details CEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,633
Closed -$8K – 9909
2020
Q4 		$8K Buy
1,633
+281
+21% +$1.24K ﹤0.01% 7663
2020
Q3 		$6K Buy
1,352
+469
+53% +$1.76K ﹤0.01% 7268
2020
Q2 		$3K Buy
883
+633
+253% +$2.21K ﹤0.01% 7594
2020
Q1 		$1K Sell
250
-454,452
-100% -$1.47M ﹤0.01% 7877
2019
Q4 		$1.43M Buy
454,702
+305,654
+205% +$829K ﹤0.01% 3873
2019
Q3 		$414K Buy
149,048
+148,298
+19,773% +$384K ﹤0.01% 4717
2019
Q2 		$2K Sell
750
-853
-53% -$3.29K ﹤0.01% 7667
2019
Q1 		$6K Sell
1,603
-1,761
-52% -$8.49K ﹤0.01% 7120
2018
Q4 		$20K Sell
3,364
-1,170
-26% -$7.64K ﹤0.01% 6804
2018
Q3 		$31K Sell
4,534
-16,688
-79% -$99.1K ﹤0.01% 6520
2018
Q2 		$121K Buy
21,222
+17,763
+514% +$121K ﹤0.01% 5304
2018
Q1 		$25K Buy
3,459
+154
+5% +$1.33K ﹤0.01% 6263
2017
Q4 		$34K Buy
3,305
+222
+7% +$2.15K ﹤0.01% 6150
2017
Q3 		$28K Buy
3,083
+1,733
+128% +$15.9K ﹤0.01% 6219
2017
Q2 		$12K Buy
1,350
+411
+44% +$4.06K ﹤0.01% 6671
2017
Q1 		$10K Sell
939
-10,404
-92% -$107K ﹤0.01% 6631
2016
Q4 		$90K Buy
11,343
+5,800
+105% +$45.1K ﹤0.01% 5368
2016
Q3 		$42K Sell
5,543
-1,088
-16% -$7.92K ﹤0.01% 5662
2016
Q2 		$43K Sell
6,631
-823,025
-99% -$6.09M ﹤0.01% 5635
2016
Q1 		$5.86M Sell
829,656
-62,487
-7% -$395K ﹤0.01% 1732
2015
Q4 		$5.53M Buy
892,143
+198,423
+29% +$1.38M ﹤0.01% 1873
2015
Q3 		$4.32M Buy
693,720
+607,326
+703% +$3.6M ﹤0.01% 2043
2015
Q2 		$330K Buy
86,394
+27,935
+48% +$122K ﹤0.01% 4438
2015
Q1 		$280K Buy
58,459
+46,445
+387% +$266K ﹤0.01% 4615
2014
Q4 		$104K Buy
+12,014
New +$117K ﹤0.01% 5669

Other funds holding CEL

CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CFG
CKW Financial Group Honolulu, Hawaii $1.02B AUM 21.34% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

UBS Group's CEL Position: Q1 2021 in Review

UBS Group sold out of Cellcom Israel, Ltd. (CEL) in Q1 2021, closing a stake of 1,633 shares — an estimated $8K sold.

UBS Group first reported a position in CEL in Q4 2014 and held it in 25 quarters. The position peaked at $5.86M in Q1 2016. 12 funds tracked by Wall St. Rank hold CEL as of Q1 2021.

  • UBS Group reported no remaining Cellcom Israel, Ltd. position as of Q1 2021 after selling out during the quarter.
  • UBS Group sold 1,633 Cellcom Israel, Ltd. shares in Q1 2021, an estimated $8K.
  • UBS Group first reported a position in Cellcom Israel, Ltd. in Q4 2014 and held it in 25 quarters.
  • UBS Group's Cellcom Israel, Ltd. position peaked at $5.86M in Q1 2016.
  • 12 funds tracked by Wall St. Rank held Cellcom Israel, Ltd. as of Q1 2021.

Based on UBS Group's 13F filing for Q1 2021, filed 12 May 2021.